Pharmcadd Raised Usd 16M In Series B Funding

Apr 19, 2021•about 4 years ago

Amount Raised

$16

Round Type

series b

Busan

Description

PharmCADD, a Korean Artificial Intelligence (AI) and Physics-based drug discovery company announced that it has finished USD 16 million series B funding on March 31, 2021.

Company Information

Company

Pharm Cadd

Location

Busan, Busan, KOR

About

AI-based In-silico Drug Design Platform 단백질 3차원 구조(Protein folding) 예측을 아미노산 서열 정보만으로 도출하는 혁신적인 기술을 보유한 인공지능 기술 기반의 바이오벤처기업입니다.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Pharmcadd Raised Usd 16M In Series B Funding

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information